FIELD: medicine.
SUBSTANCE: invention refers to medicine, specifically to cardiovascular surgery and can be applied within heart surgical procedures experimentally. For this purpose perfusion is retrograde conducted through aortic cannula with oxygenated solution at first and then with non-oxygenated solution combined with liposome addition under specified conditions. Method provides restoration of contractile function and heart rhythm due to liposomic stabilisation of cell membranes and reduction of lipid peroxidation product.
EFFECT: restoration of contractile function and heart rhythm.
2 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIISCHEMICALLY-ACTIVE AGENT | 1988 |
|
RU2007985C1 |
APPARATUS FOR PERFUSION PRESERVATION AND RECONDITIONING OF A DONOR HEART | 2020 |
|
RU2754592C1 |
"INFUSOL" CARDIOPLEGIC SOLUTION | 2002 |
|
RU2226093C1 |
METHOD FOR RECONDITIONING A DONOR HEART | 2021 |
|
RU2777097C1 |
AGENT AGAINST MYOCARDIAL HYPOXIA | 2013 |
|
RU2522953C1 |
METHOD OF DETERMINING REPERFUSED INJURY OF MYOCARDIUM AFTER ISCHEMIA | 0 |
|
SU1570707A1 |
METHOD FOR ASSESSING MYOCARDIAL INJURY IN ISOLATED HEART PERFUSION BY LANGENDORFF METHOD | 2023 |
|
RU2814370C1 |
METHOD OF HEARTBEAT RECOVERY FOLLOWING DIASTOLIC ARREST IN EXPERIMENT | 2010 |
|
RU2424582C1 |
METHOD FOR PRESERVING MYOCARDIUM ACCOMPANYING TRANSPLANTATION | 2013 |
|
RU2535036C1 |
METHOD OF SIMULATING ACUTE HEART ISCHEMIA | 0 |
|
SU1381397A1 |
Authors
Dates
2008-06-10—Published
2002-06-17—Filed